Explore how rising diabetes-driven kidney failure is escalating Medicare costs and straining transplant resources, highlighting the need for early intervention and Medicaid's critical role.

The pending domestic policy bill proposes significant Medicare payment cuts, expanded HSA contributions post-Medicare enrollment, rural hospital classifications, and tightened eligibility rules, impacting coverage and payment structures.

True Heart Insurance, led by Joshua Dixson, earns CMS Elite Plus status for enrolling 500+ consumers in qualified health plans, enhancing access and expertise in Greenville, SC.

House Republicans pass budget bill enacting largest Medicaid cuts in U.S. history, adding tax breaks for the wealthy and increased immigration enforcement funding. Impact on healthcare premiums and federal deficit noted.

Explore the implications of proposed Medicare and Medicaid funding cuts on older adults and underserved communities, highlighting the role of nursing leaders and the aging U.S. population's healthcare needs.

CMS excludes obesity drugs from 2026 Medicare coverage, citing cost concerns; Eli Lilly criticizes the decision impacting obesity management treatments.

FDA refocuses COVID vaccine approvals on high-risk groups with new evidence requirements. Medicare fraud case results in sentencing for $3.2M scheme. Lower-income countries increase self-funded vaccine investments. Bipartisan prior authorization reform bill returns in Congress.

Ceresti Health opens a Medicare GUIDE wait list enabling family caregivers nationwide to access tech-enabled dementia care under CMS's new Medicare program launching July 2025. No cost to patients or caregivers.

ASTRO backs bipartisan legislation to reform Medicare Advantage prior authorization, aiming to reduce cancer treatment delays and improve care outcomes.

HHS and CMS unveil Most Favored Nation drug pricing model targeting pharmaceutical manufacturers to align U.S. drug prices with international benchmarks and reduce costs.